Tuesday, December 31, 2002 12:57:57 PM
Best wishes for 2003.
JR
Recent MRKR News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 12/30/2024 09:46:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2024 09:01:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 09:40:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 09:30:19 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 12/23/2024 09:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2024 01:21:17 PM
- Marker Therapeutics Announces $16.1 Million Private Placement • GlobeNewswire Inc. • 12/19/2024 01:06:43 PM
- Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma • GlobeNewswire Inc. • 12/19/2024 01:05:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 12:10:42 PM
- Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer • GlobeNewswire Inc. • 12/17/2024 12:00:19 PM
- Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium • GlobeNewswire Inc. • 12/10/2024 01:30:44 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/06/2024 09:30:26 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/27/2024 09:27:23 PM
- Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit • GlobeNewswire Inc. • 11/26/2024 04:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 09:45:17 PM
- Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/14/2024 09:30:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:05:42 PM
- Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:47:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:39:13 PM
- Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/14/2024 08:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:12:59 AM
- Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma • GlobeNewswire Inc. • 08/12/2024 11:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:05:47 PM
FEATURED Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • Jan 9, 2025 8:49 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM
Fifty 1 Labs, Inc. Launches Dedicated Website for Shareholders and Investors, Company now current with OTC Markets • CAFI • Jan 7, 2025 9:00 AM
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion • EZFL • Jan 7, 2025 8:35 AM
CGRA Signs Binding Term Sheet to Merge With American Infrastructure Corporation, a Subsidiary of Nasdaq-listed American Resources Corporation (Nasdaq: AREC) • CGRA • Jan 6, 2025 10:31 AM